# US 2025/0146071 A1 · Method for transposase-mediated spatial tagging and analyzing genomic dna in a biological sample

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0146071 A1
- Document ID: US20250146071A1
- Status: Published application
- Kind: A1
- Application number: 19/020,320
- Filed: 2025-01-14
- Published: 2025-05-08
- Earliest claimed: 2018-08-28
- Assignees: 10x Genomics, Inc.
- Applicants: 10x Genomics, Inc.
- Inventors: Michael Schnall-Levin; Michael Ybarra Lucero; Tarjei Sigurd Mikkelsen; Patrik Stahl; Jonas Frisen; Maja Marklund; Enric Llorens Bobadilla
- Web page: https://patentgrep.com/patent/US20250146071A1

## CPC

- C12Q 1/6881: for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
- C12Q 1/48: involving transferase
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6841: In situ hybridisation
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Y 207/07: Nucleotidyltransferases (2.7.7)
- G01N 2458/10: Oligonucleotides as tagging agents for labelling antibodies
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Y: ENZYMES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present disclosure relates to materials and methods for spatially analyzing nucleic acids that have been fragmented with a transposase enzyme, alone or in combination with other types of analytes.

## Claims

### Claim 1

A method for determining the spatial location of a nucleic acid in a tissue sample, the method comprising:
(a) contacting the tissue sample with an array comprising a plurality of capture probes affixed thereon, wherein a capture probe of the plurality of capture probes comprises (i) a spatial barcode and (ii) a capture domain;
(b) permeabilizing the tissue sample;
(c) contacting a transposome with the permeabilized tissue sample to insert transposon end sequences into the nucleic acid, thereby generating a fragmented nucleic acid sequence, and adding to an end of the fragmented nucleic acid sequence a first adapter comprising a sequence substantially complementary to a sequence of the capture domain;
(d) hybridizing the first adapter of the fragmented nucleic acid sequence to the capture domain of the capture probe; and
(e) determining the spatial barcode sequence or a complement thereof, and the fragmented nucleic acid sequence adjacent to the first adapter and the transposon end sequence, or a complement thereof, thereby determining the spatial location of the nucleic acid in the tissue sample.
